Logo
Login

Company Executives

$ Management Team

Mr. Christian Angermayer

Chairman of the Supervisory Board

Age 46
Compensation $2.161M USD
Sex Male

Dr. Srinivas Rao

Chief Executive Officer

Co-Founder

Interim Managing Director

Age 56
Compensation $3.463M USD
Sex Male

Mrs. Anne Johnson

Chief Financial Officer

Age 55
Compensation $1.502M USD
Sex Female

Dr. Gerd Kochendoerfer

Chief Operating Officer

Age 57
Compensation -
Sex Male

Dr. Glenn Short

Chief Scientific Officer

Age 55
Compensation -
Sex Male

Dr. Kevin Craig

Chief Medical Officer

Age 52
Compensation -
Sex Male

Board of Directors

From the proxy statement filed Apr 22, 2026
Directors
9
serving now
Independent
0 of 2
stated in the proxy; 7 not stated
Average tenure
3.0 years
from year joined
CEO also chairs the board
No
Christian Angermayer
Director Age On board Independent Committees Other public boards 2025 pay Source
Srinivas Rao, M.D., Ph.D.
CEO
 57 2025
1 year
 Not independent None stated None stated Paid as CEO
Christian Angermayer
Board chair
 47 2021
5 years
 Not independent None stated None stated $517,839
Scott Braunstein, M.D.
62 2024
2 years
 Not stated
Audit
Caribou Biosciences, Inc. $496,713
Laurent Fischer, M.D.
62 2024
2 years
 Not stated
Compensation · Chair
Mirum Pharmaceuticals, Inc. $237,949
Robert Hershberg, M.D., Ph.D.
63 2025
1 year
 Not stated
Nominating
Adaptive Biotechnologies $364,752
John Hoffman
42 2025
1 year
 Not stated
Audit Compensation
None stated $396,103
Andrea Heslin Smiley
58 2021
5 years
 Not stated
Nominating · Chair
Rockwell Medical, Inc. $254,449
Amir Kalali, M.D.
60 2021
5 years
 Not stated
Nominating
None stated Not stated
Sabrina Martucci Johnson
59 2021
5 years
 Not stated
Audit · Chair Compensation
None stated $254,449

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 22, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans